MDxHealth (MDXH) Gross Profit (2021 - 2026)

MDxHealth (MDXH) has 6 years of Gross Profit data on file, last reported at $16.6 million in Q1 2026.

• Quarterly Gross Profit rose 7.16% year-over-year to $16.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $70.7 million (up 20.76% YoY) and the FY2025 annual result came in at $69.6 million, up 26.28% from the prior year.
• Gross Profit retreated to $16.6 million in Q1 2026 per MDXH's latest filing, from $18.7 million in the prior quarter.
• The five-year high for Gross Profit was $18.7 million in Q4 2025, with the low at -$2.8 million in Q2 2022.
• Average Gross Profit over 5 years is $11.7 million, with a median of $12.7 million recorded in 2023.
• Year-over-year, Gross Profit surged 452.1% in 2023 and advanced 7.16% in 2026.
• MDxHealth's Gross Profit stood at $7.2 million in 2022, then soared by 75.4% to $12.7 million in 2023, then grew by 22.46% to $15.5 million in 2024, then climbed by 20.43% to $18.7 million in 2025, then declined by 11.09% to $16.6 million in 2026.
• Business Quant data shows MDXH's Gross Profit at $16.6 million in Q1 2026, $18.7 million in Q4 2025, and $17.9 million in Q3 2025.